<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Kas iskelet sistemi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/kas-iskelet-sistemi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 18 Nov 2025 14:36:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Kas iskelet sistemi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Vincristine Disrupts Musculoskeletal Growth in Mice</title>
		<link>https://bioengineer.org/vincristine-disrupts-musculoskeletal-growth-in-mice/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 18 Nov 2025 14:36:32 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Fare modeli** **Kısaca açıklama:** 1. **Vincristin toksisitesi:** Çalışmanın ana konusu vincristin]]></category>
		<category><![CDATA[İşte bu yazı için 5 uygun etiket (virgülle ayrılmış): **Vincristin toksisitesi]]></category>
		<category><![CDATA[Kas iskelet sistemi]]></category>
		<category><![CDATA[Kemoterapi komplikasyonları]]></category>
		<category><![CDATA[Pediyatrik onkoloji]]></category>
		<guid isPermaLink="false">https://bioengineer.org/vincristine-disrupts-musculoskeletal-growth-in-mice/</guid>

					<description><![CDATA[In a groundbreaking study published in BMC Cancer, researchers have unveiled the profound impact of vincristine—a cornerstone chemotherapeutic agent used in pediatric oncology—on the musculoskeletal development of young mice. Despite the impressive survival rates exceeding 85% for children diagnosed with cancer, long-term complications following chemotherapy remain a significant concern. This research sheds light on the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">298238</post-id>	</item>
	</channel>
</rss>
